About Anand Srivastava
Form D filings for Cellebration Life Sciences from 2021 to 2023 list Anand Srivastava as director.
Anand Srivastava first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Anand Srivastava in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Anand Srivastava works with at each company, as listed on that company's latest Form D.
Cellebration Life Sciences, Inc. · Form D/A, Aug 21, 2023